Angio News and Research

RSS

'Seeing' stem cells helps in fight against peripheral arterial disease

Interventional radiologists are fitting together the puzzle pieces of how to use stem cells to create new or more blood vessels to treat peripheral arterial disease (PAD) in those individuals with extensively narrowed or clogged arteries.

11 Mar 2009

St. Jude Medical gets U.S. and European approval of Angio-Seal Evolution Vascular Closure Device

St. Jude Medical, Inc. has announced U.S. Food and Drug Administration (FDA) and European CE Mark approval of the Angio-Seal Evolution Vascular Closure Device. The approval and global launch was announced at the Transcatheter Cardiovascular Therapeutics conference in Washington, D.C.

14 Oct 2008

Improving understanding of cell behaviour in breast cancer

The invasion and spread of cancer cells to other parts of the body, known as metastasis, is a principal cause of death in patients diagnosed with breast cancer. Although patients with early stage, small, breast tumours have an excellent short term prognosis, more than 15 to 20 per cent of them will eventually develop distant metastases, and die from the disease. Vascular invasion - through lymphatic and blood vessels - is the major route for cancer spreading to regional lymph nodes and to the rest of the body.

15 Jul 2008

Angiotech receives FDA clearance to market 5-Fluorouracil-coated central venous catheter

Angiotech Pharmaceuticals, Inc. has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its innovative 5-Fluorouracil-coated (5-FU) Central Venous Catheter (CVC) in the United States.

17 Apr 2008

Vaccines for measles-mumps-rubella and varicella are effective in extremely preterm infants

The study, which included 16 term and 16 extremely preterm (born before about 6 months of pregnancy) infants born between May 2002 and May 2005, is the first of its kind to examine the antibody levels of measles, mumps, rubella and varicella in this population before and after vaccination. It was published in this month's Pediatrics.

5 Mar 2007

Rates of eczema and hay fever falling

After having risen year on year in recent decades, the rates of eczema and hay fever seem to have stabilised, and may even be falling, suggests research published ahead of print in Thorax.

30 Aug 2006

Ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine

Some ethnic groups may be more susceptible to adverse drug reactions, finds a study published online in the British Medical Journal.

9 May 2006

MRI Patients in Canadian capital cities are getting the procedure sooner than regional areas

Patients in the Capital district who need an MRI are getting the procedure a lot sooner. The average wait time is now 45.2 days, almost three times less than the 148.2 days people were waiting last March. The wait time standard for elective MRI procedures is 42 days. Urgent or emergency MRIs are done immediately.

18 Apr 2004

Angio News and Research

'Seeing' stem cells helps in fight against peripheral arterial disease

St. Jude Medical gets U.S. and European approval of Angio-Seal Evolution Vascular Closure Device

Improving understanding of cell behaviour in breast cancer

Angiotech receives FDA clearance to market 5-Fluorouracil-coated central venous catheter

Vaccines for measles-mumps-rubella and varicella are effective in extremely preterm infants

Rates of eczema and hay fever falling

Ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine

MRI Patients in Canadian capital cities are getting the procedure sooner than regional areas

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News